Circle Pharma

South San Francisco, CA · Founded 2012 · Privately Held (backing)

Developer of a new generation of macrocycle therapies designed for cell-permeable delivery and can be delivered by multiple routes, including oral administration. Circle Pharma is based in South San Francisco, CA and was founded in 2012. It was valued at $269 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $212 million across 4 recorded rounds; the latest was a $92.4 million later-stage round in Jun 2024.

PMV mark · valuation
$269.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$212.1M
Last round
Later Stage VC
Jun 2024
Team — not yet on record

No current team members for Circle Pharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Circle Pharma with a free account
  • ·The complete investor list: 23 names
  • ·Watch Circle Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View